$EHTH

Modular Medical (MODD) received FDA clearance for software enhancements to its Pivot insulin pump, planning a commercial launch in October 2026. Galmed (GLMD) shareholders approved all proposals, including a name change. Pro-Dex (PDEX) reported strong Q4 results with 17% sales growth. eHealth (EHTH) saw after-hours gains despite a Q2 net loss. Connect Biopharma (CNTB) will present at a conference and report Phase 2 trial results. AVITA Medical (RCEL) expects full-year revenue of $86M-$89M.

eHealth, Inc. (Nasdaq: EHTH) reported its second-quarter 2026 financial results for the period ended June 30, 2026, according to the company’s earnings release. The firm scheduled a webcast and conference call on Aug. 4, 2026 at 5:00 p.m. ET, with materials posted on its Investor Relations site.

eHealth, Inc. (EHTH) filed an SEC Form 8-K — Results of Operations and Financial Condition. eHealth, Inc. Announces Second Quarter 2026 Results Lifetime Advisory Model increasing member engagement On track to achieve meaningful YoY improvements in annual operating cash flow INDIANAPOLIS — August 4, 2026 — eHealth, Inc. (Nasdaq: EHTH), a leading private online health ins

eHealth, Inc. (EHTH) is scheduled to report Q2 2026 earnings on Aug. 4 after market close, with results expected at 4:00 PM ET. The article cites a Q2 2026 revenue estimate of $33.28 million and an EPS estimate of -$0.84.

eHealth, Inc. (EHTH) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. EX-10.1 2 ar2024equityincentiveplanj.htm EX-10.1 Document EHEALTH, INC. AMENDED AND RESTATED 2024 EQUITY INCENTIVE PLAN 1. Purposes of the Plan . The purposes of this Plan are: • to attract and retain the best available personnel for positions of substantial responsibility, • to

eHealth, Inc. held its Q1 2026 earnings call, discussing financial results that exceeded expectations due to strong Medicare enrollment and favorable unit economics. The company emphasized its strategic shift towards profitability over volume, implementing cost reductions, launching a new "lifetime advisory model" and final expense insurance product, and projecting a return to revenue growth by 2027 with expanding adjusted EBITDA margins. Management maintained its 2026 guidance while updating its outlook for net adjustment revenue, focusing on strengthening its foundation amidst the ongoing Medicare Advantage market reset.

eHealth, Inc.'s Chief Revenue Officer, Michelle Marie Barbeau, reported a tax-related disposition of 3,571 shares of common stock at $1.89 per share to satisfy tax withholding obligations. This transaction is a routine settlement for equity compensation, not an open-market sale. Following this activity, Barbeau directly holds 309,094 shares of EHTH.

eHealth, Inc.'s Senior Vice President and General Counsel, Gavin G. Galimi, reported a tax-related disposition of 3,588 shares of common stock. These shares, valued at $1.89 each, were withheld to satisfy a tax withholding obligation associated with equity compensation, rather than being sold in the open market. Following this transaction, Galimi directly owns 277,158 shares of eHealth common stock.

eHealth, Inc.'s Chief Financial Officer, John Joseph Dolan, reported a tax-related disposition of 4,206 shares of common stock on April 24, 2026. These shares were withheld at $1.89 per share to satisfy a tax withholding obligation, rather than being sold on the open market. Following this transaction, Dolan directly holds 275,240 shares of eHealth Common Stock, indicating a routine, compensation-related tax withholding.

Andrea Brimmer, a long-serving board member of eHealth, Inc., will be stepping down from her position when her current term expires on June 18, 2026. Brimmer has been a valued member for nearly eight years, and her departure signifies a transition for the online health insurance marketplace as it navigates an evolving industry landscape. While CEO Derrick Duke expressed gratitude for her contributions, the company will need to identify a new board member to fill the role.